Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients (Q45231516)

11 December 2017

title

Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients (English)

1 reference

11 December 2017

0 references

cervix uterine cancer

1 reference

3

Ki-Hong Chang

1 reference

11 December 2017

Hee-Sug Ryu

1

1 reference

11 December 2017

Mison Chun

series ordinal

2

1 reference

11 December 2017

Hye-Jin Chang

series ordinal

4

1 reference

11 December 2017

Jung-Pil Lee

series ordinal

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

96

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

490-495

1 reference

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Radiotherapy versus surgery in the treatment of cervix stage Ib cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Postoperative radiation for cervical cancer with pathologic risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Results of radiation therapy given after radical hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Concurrent chemoradiotherapy in cervical cancer (a new paradigm in cervical cancer treatment).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Chemoradiation for carcinoma of the cervix: advances and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2004.10.038

10.1016/J.YGYNO.2004.10.038

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference